Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 内蒙古福瑞医疗科技股份有限公司是一家集科研、生产、销售、网络服务为一体的现代化医药企业,一直专注于肝病领域,目前以提供肝纤维化诊断治疗产品和服务为主营业务,主要产品为复方鳖甲软肝片.复方鳖甲软肝片是国家专利产品、国家二级中药独家保护品种,1999年荣获国家科技进步三等奖,2001年被内蒙古科技厅认定为高新技术成果,2004年,公司复方鳖甲软肝片高新技术产业化示范工程被列入国家级火炬计划项目。 | ||||||||||||||||||||||||
Main Business | 肝病领域的药品生产与销售、诊断设备研发与销售以及医疗服务相关业务。 | ||||||||||||||||||||||||
Legal Representative | 王冠一 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 孙秀珍 | ||||||||||||||||||||||||
Solicitors | 北京京都律师事务所 | ||||||||||||||||||||||||
Auditors | 立信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 010-84683855 | ||||||||||||||||||||||||
Fax No | 010-84683766 | ||||||||||||||||||||||||
Website | www.fu-rui.com | ||||||||||||||||||||||||
dshbgs@fu-rui.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 20/01/2010 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.386 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 5.882 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 7.575B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |